4[2]Sabbah HN cellular and physiologiCeffect of beta blockers in heart failer clin cardiol,1999,22(SUPPL):V16
5[3]CoLucc:WS The effect of norepinephrine on myocardial biologg:im plications for the therapy of heart failure clin cardio,1998,(21,3upp11):120.
6Feinberg WM, Blackshear JL, Laupacis A,et al. Prevalence, age distribution, and gender of patients with at rial fibrillation. Analysis and implications. Arch Intern Med,1995,155(5):469 -473.
7Benjiamin EJ, Wolf PA, DA' gostino RB, et al. Impact of atrial fibrillation on the risk of death:the framingham heart study. Circulation, 1998,98(10):946 - 952.
8Wolf PA, Abbort RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke:the framing, ham study. Stoke,1991,22 (8):983 - 988.
9Sabbah HN. The cellular and physiologic effect of beta blockers in heart failer[J]. Clin cardiol, 1999, 22 (suppl): v16-v20.
10Colucci WS. The effects of norepinephrine on myocrdial biology:implications for the therapy of heart failure[J]. Clin Cardio, 1998,21 (12, suppl 1): 120-124.
